Distributor inventory
Bromocriptine 1.25 mg (as bromocriptine mesylate) per tablet
Treatment of hyperprolactinaemia (amenorrhoea, galactorrhoea, infertility), prolactinoma, acromegaly (adjunct), Parkinson’s disease (adjunct), type 2 diabetes mellitus (where prescribed as bromocriptine quick-release)
Bromocriptine is an ergot-derived dopamine D2 receptor agonist. It inhibits prolactin release from the pituitary gland, reducing prolactin levels and related symptoms. Dopaminergic activity also helps improve motor symptoms in Parkinson’s disease and can improve glycaemic control with the quick-release formulation.
Take orally exactly as prescribed, preferably with food to reduce nausea. Usually started at a low dose and increased gradually. Take at the same time each day; do not stop abruptly without medical advice.
Common side effects of SICRIPTIN 1.25MG 10S may include:
May cause dizziness/low blood pressure—rise slowly from sitting/lying; avoid driving if drowsy. Use with caution in patients with cardiovascular disease, psychiatric disorders, liver impairment, or history of fainting. Rare risks include severe hypotension, hallucinations/impulse control disorders, and fibrotic complications with long-term/high-dose ergot derivatives. Not recommended for routine suppression of lactation; seek medical advice if postpartum hypertension or pre-eclampsia. Monitor prolactin/clinical response as advised.
